Evaluation of the Efficacy and Safety of Olanzapine for Anorexia Nervosa in Children and Adolescents
NCT01184443
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
38
Enrollment
OTHER
Sponsor class
Stopped
Poor recruitment
Conditions
Eating Disorder
Interventions
DRUG:
Olanzapine
Sponsor
Children's Hospital of Eastern Ontario